Principal Key Account Manager
NextRollFull Time
Senior (5 to 8 years)
The candidate must be based in Sao Paulo and possess a Bachelor's degree in a related business or scientific discipline. Required experience includes pharmaceutical/biotechnology sales or key account management with high-cost products, and hands-on experience interacting with third parties and patient organizations. Experience with specialty pharmacy distribution and patient access services is also necessary. Experience with rare diseases is desirable.
The Key Account Manager will represent PTC's products to medical professionals within an assigned geographic region, building business partnerships with healthcare providers and staff. Responsibilities include increasing awareness through scientific information and education, developing and executing regional action plans to achieve sales goals, and understanding marketing plan objectives. The role involves creating consultative partnerships with customers, identifying key treatment centers, driving patient identification initiatives, and managing relationships with health authorities, key opinion leaders, patient organizations, and payors. The manager will also resolve product access and reimbursement issues, provide training on product use, communicate drug information and side effects to the Pharmacovigilance Department, and collaborate with internal teams to drive commercial business.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.